Abstract | Spina bifida is a birth defect in which the vertebral column is open, often with spinal cord involvement. The most clinically significant subtype is myelomeningocele (open spina bifida), which is a condition characterized by failure of the lumbosacral spinal neural tube to close during embryonic development. The exposed neural tissue degenerates in utero, resulting in neurological deficit that varies with the level of the lesion. Occurring in approximately 1 per 1,000 births worldwide, myelomeningocele is one of the most common congenital malformations, but its cause is largely unknown. The genetic component is estimated at 60-70%, but few causative genes have been identified to date, despite much information from mouse models. Non-genetic maternal risk factors include reduced folate intake, anticonvulsant therapy, diabetes mellitus and obesity. Primary prevention by periconceptional supplementation with folic acid has been demonstrated in clinical trials, leading to food fortification programmes in many countries. Prenatal diagnosis is achieved by ultrasonography, enabling women to seek termination of pregnancy. Individuals who survive to birth have their lesions closed surgically, with subsequent management of associated defects, including the Chiari II brain malformation, hydrocephalus, and urological and orthopaedic sequelae. Fetal surgical repair of myelomeningocele has been associated with improved early neurological outcome compared with postnatal operation. Myelomeningocele affects quality of life during childhood, adolescence and adulthood, posing a challenge for individuals, families and society as a whole. For an illustrated summary of this Primer, visit: http://go.nature.com/fK9XNa PRIMER NATURE REVIEWS | DISEASE PRIMERS VOLUME 1 | 2015 | 1
Spina bifida is a congenital malformation in which the spinal column is split (bifid) as a result of failed closure or formation of the embryonic neural tube. The most common and severe form is myelomeningo cele (also termed open spina bifida or spina bifida aperta) (FIG. 1) , which is the focus of this Primer. In myelomeningocele, the spinal cord is open dorsally, forming a placode on the back of the fetus or newborn baby; this placode frequently rests on a meningeal sac (then termed spina bifida cystica 1 ). The vertebrae at the level of the lesion lack neural arches and are incomplete dorsally.
Individuals with myelomeningocele often exhibit neuro logical deficits below the level of the lesion, involving both motor and sensory functions. This def icit might result in lowerlimb weakness or paralysis that hinders or prevents walking, and lack of sensation that enhances the risk of pressure sores. Urinary and faecal incontinence occurs frequently, as do hindbrain herniation (the Chiari II malformation) and associ ated hydrocephalus, which often requires shunting. Orthopaedic abnormalities such as talipes (club foot), contractures, hip dislocation, scoliosis and kyphosis are frequently observed. A strong correlation is appar ent between the axial level of lesion and the degree of disability experienced by patients. A 40year followup study of 117 children whose lesions were repaired in the United Kingdom during the 1960s and 1970s found a 17% survival rate among those with lesions above the eleventh thoracic vertebra (T11); by contrast, 61% of individuals with lesions below the third lumbar ver tebra (L3) were alive at the end of the study 2 . Fewer survivors were mobile (community walkers) and free of pressure sores in the 'above T11' group than in the 'below L3' group.
The lifetime cost of caring for a child born with myelomeningocele is estimated at more than €500,000 (US$600,000), comprising €185,000 ($222,000) in direct medical costs and the remainder in indirect costs, including special educational and caregiver needs, and loss of employment potential 3 . In view of these lifechanging health and economic consequences, con siderable effort has been invested in exploring the patho physiological mechanisms of the disorder, finding better ways to treat and manage the condition and its con sequences, and progressing towards the ultimate goal of primary prevention. This Primer considers the main areas of progress to date and discusses developments that might further improve the outlook for individuals with myelomeningocele.
Epidemiology
Many epidemiological studies group spina bifida together with the related defect anencephaly, and sometimes also with encephalocele, under the general term neural tube defects (NTDs) (FIG. 1) . The prevalence of NTDs has var ied considerably over the past four decades 4 and contin ues to show substantial differences between geographical locations. For example, the prevalence of NTDs in the United States and many European countries is estimated at 0.5-0.8 cases per 1,000 births 5 , whereas the prevalence in some regions of China has been reported to be more than 20 times as high 6 . Assuming an average prevalence of one NTD case per 1,000 births, with a global popula tion of 7 billion and a yearly birth rate of 20 per 1,000 individuals, this generates a figure of 140,000 NTD cases per year worldwide. Regions of higher NTD prevalence have uniquely shown disproportionately high frequen cies of rare subtypes such as craniorachischisis and ini encephaly 7 . Further, withincountry differences have been observed between racial and ethnic groups. For exam ple, in the United States, the prevalence of spina bifida is higher in Hispanics 8 and lower in African Americans 9 than in nonHispanic whites. Prevalence differences in time and across geographical regions have been attributed to variations in ascertainment methods, as well as to true differences in risk. Indeed, the ascertainment of NTD prevalence is challenging, as antenatal screening pro cedures can lead to diagnosis and sub sequent pregnancy termination. Accordingly, the omission of such elective terminations from the data clearly leads to an under estimation of NTD prevalence and might bias risk estima tions in aetiological studies 10 . EUROCAT, the European network of populationbased registries for epidemiologi cal surveillance of congenital anomalies, collects data on pregnancy terminations in addition to live births and still births, generating particularly comprehensive prevalence data for NTDs and other malformations. For the period [2003] [2004] [2005] [2006] [2007] , EUROCAT estimated the prevalence of spina bifida and NTDs (including chromosomally related dis orders) at 0.51 and 0.94, respectively, per 1,000 births, stillbirths and pregnancy terminations 11 . Both genetic and nongenetic factors contribute to NTDs. Heritability (the genetic component of risk) was estimated at 60-70% on the basis of the relative propor tions of affected siblings as analysed in prevalence sur veys in the 1960s in South Wales, Glasgow and London, UK 12 . Fewer than 10% of NTDs are syndromic -for example, occurring in chromosomal disorders such as trisomy 13 or trisomy 18 -whereas the great majority are nonsyndromic and exhibit a sporadic pattern of occurrence. Several lines of evidence support a multi factorial causation model for nonsyndromic NTDs, involving multiple genes and nongenetic factors 13 . The recurrence risk for siblings of an index case is 2-5%, representing a 20fold to 50fold increase in risk com pared with the general population 4 . Seconddegree and thirddegree relatives show lower recurrence risks than firstdegree relatives, but still higher risks than un related individuals. For a particular woman, the empirical recurrence risk for subsequent offspring with NTDs after an affected pregnancy is ~3%, rising to ~10% after two affected pregnancies 4 . In twins, the concordance for NTDs is higher among samesex twin pairs (both monozygotic and dizygotic) than among oppositesex twin pairs. The finding that more fetuses and infants with anencephaly are female, has strongly suggested a sexrelated genetic or epigenetic component to an encephaly 14 . Finally, the prevalence differences between ethnic groups have been reported to persist in some cases after migration to other geographical loca tions 15 . Hence, considerable evidence points to a major genetic component in spina bifida causation, raising the question of which genes are implicated.
Considering nongenetic factors, diminished folate status is undoubtedly the bestknown factor influenc ing NTD risk. Beyond folate, a number of other nutri ents and nutritionrelated factors have been linked with NTDs
. The association with maternal obesity is particularly notable and has been consistently reported in studies from a variety of populations worldwide 16 . Interestingly, these maternal obesityassociated risks are stronger for spina bifida than for anencephaly [16] [17] [18] and might not be reduced by maternal folic acid use 19 . For spina bifida, elevated risks in the range of 1.5fold to 3fold have been consistently observed. In addition, severe maternal obesity (a body mass index of >35) has been associated with even larger risks for the offspring, indicative of a dose-response relationship linking mater nal obesity with spina bifida. Suggested mechanisms underlying this potential link include aberrant glucose control, oxidative stress and metabolic syndrome 18 . Other nongenetic factors that have been linked with NTDs include exposure to a variety of environmental factors, such as pollutants and personal toxicants
. However, most of these factors have not been consist ently observed, are relatively infrequent in occurrence, or have not shown a high magnitude of risk. Thus, such factors are unlikely to explain a substantive proportion of the population burden of NTDs 20 .
Mechanisms/pathophysiology
The primary disorder in the pathogenesis of myelo meningocele is failed neural tube closure in the embry onic spinal region, which leads to prolonged exposure of the open neural tube to the amnioticfluid environ ment. Remarkably, the bifid neuroepithelium initially undergoes relatively normal neuronal differentiation, with the development of spinal motor and sensory function even below the lesion level. As gestation Author addresses 1 progresses, however, the exposed spinal cord becomes haemorrhagic, and neurons die as a result of the toxi city of the amniotic fluid
. Axonal connections are interrupted and function is lost 21 . Hence, the neuro logical disability is often considered a twohit process: failed neural tube closure followed by neurodegenera tion in utero. Accordingly, attempts to cover the lesion during fetal development have been encouraged, to arrest or prevent neurodegeneration in individuals for whom closure has failed.
Genetic factors
More than 200 genes are required for successful neu ral tube closure in mice, with new examples of essen tial genes being described on a regular basis 22 . These genes relate to a wide range of cellular functions (such as cytoskeletal regulation, transcriptional regulation and cell proliferation control) and molecular pathways (including Hedgehog, bone morpho genetic protein and retinoid signalling) 23 , and mutant models display a variety of phenotypes that mimic the range of human NTDs. Exencephaly, the developmental precursor of anencephaly, is the most commonly encountered NTD following mutation of these genes in mice and is associated with more than 150 genes. However, myelo meningocele is observed in more than 40 mutant mouse strains, often in combination with exencephaly but in several cases as the only NTD 22, 24 . For many of these genes, sequencing of the coding regions of human orthologues has revealed that patients with NTDs often carry rare missense (that is, amino acid altering) mutations that are absent from unaffected • Low socio-economic status 209 • Maternal infections and illnesses 210 • Pregestational insulin-dependent diabetes 211 • Pregestational obesity 17 • Psychosocial stress 212, 213 • Valproic acid use 214 
Environmental factors
• Ambient air pollution 215, 216 • Disinfectant by-products in drinking water 217 • Indoor air pollution 218 • Nitrate-related compounds 219 • Organic solvents 220 • Pesticides 221, 222 • Polycyclic aromatic hydrocarbons 223 individuals. In particular, variants of genes involved in the planar cell polarity pathway (a noncanonical WNT signalling cascade) have been associated with a range of NTDs 25 . This finding is particularly important because gene mutations in this pathway often result in NTDs in mice, generating several pheno types, including the severe malformation crani orachischisis, which is an almost completely open brain and spine 26 . A second group of NTDassociated genes are those encoding enzymes that function in folate onecarbon metabolism, which is essential both for the synthesis of nucleotides (as the building blocks of DNA) and for methylation reactions that control gene expression and other cellular functions. Included in this enzyme group is 5,10methylenetetrahydrofolate reductase (encoded by MTHFR), an enzyme that produces 5methyl tetrahydrofolate, which is essential for the conversion of homocysteine into methionine. The MTHFR C677T variant, which results in the conver sion of valine to alanine at codon 222, reduces the activity of this enzyme. Indeed, this mutation in either the mother or fetus can be a risk factor for NTDs in populations of nonLatin origin, particularly when the folate status of the mother is low 27 . However, in mice, Mthfr knock out does not generate NTDs 28 , raising a question about the specificity of this genetic associ ation with NTDs. By contrast, mutations in genes of the glycine cleavage system have been found among patients with NTDs and, in this case, loss of function of the mouse orthologues also produces NTDs 29, 30 . These mutations in the glycine cleavage system genes reduce the activity of glycine decarboxylase and amino methyl transferase, which mediate the breakdown of glycine within mitochondria, a key step in cellular folate onecarbon metabolism.
Non-genetic factors
Although various environmental factors have been linked with NTDs
, only a few clues exist about the pathogenetic mechanisms that cause these dis orders. Moreover, it seems likely that nongenetic factors influ ence neural tube closure mainly when combined with a predisposing genotype. The anticonvulsant valproic acid increases risk in the fetus approximately tenfold when taken by the mother during the first trimester of pregnancy 31 . The potent histone deacetylase inhibi tory activity of this anticonvulsant might disturb the balance of protein acetylation and deacetylation, lead ing to failure of neurulation (the folding of the neural plate to create the neural tube) 32 . The fungal product fumonisin was demonstrated to cause NTDs in stud ies of an 'outbreak' of NTDs in southern Texas, USA, linked to contamination of tortilla flour 33 . Exposure of rodent embryos to fumonisin led to the identifica tion of sphingosine phosphate metabolism as a key target of the toxin; perturbation of this pathway would potentially compromise folate utilization 34 . Maternal dia betes mellitus predisposes the fetus to a range of birth defects, and NTDs occurring in this context are caused by hyper glycaemia, although the pathogenetic mechanism is poorly understood. One suggestion implicates disrupted fetal expression of PAX3 (REF. 35 ), loss of function of which leads to NTDs in mice.
Embryonic pathogenesis of myelomeningocele
Two distinct phases of neural tube formation occur in higher vertebrates: primary (closure) and secondary (canalization) (FIG. 2) . In humans, primary neurulation is initiated at the boundary between the future hindbrain and the cervical spine on day 22 postfertilization. From this level, the neural tube 'zips up' bidirectionally up into the hindbrain and down the spine. Closure initiates separately at the rostral extremity of the forebrain, and zipping proceeds backwards from this site to meet the wave of forward closure from the hindbrain. Cranial closure is completed at the rostral neuropore on day 24, whereas spinal closure continues for a longer period, forming progressively lower levels of the neuraxis until it finishes at the caudal (posterior) neuropore on day 26 (REF. 36 ). This event marks the completion of the spinal cord to the upper sacral level.
NTDs can result from failure of any part of this neurulation sequence and they are typically open defects, owing to the arrest of closure before fusion of the neural folds in the dorsal midline (FIG. 2a-c) .
The most severe spinal defect is craniorachischisis, in which closure fails to be initiated on day 22. Analyses of mice with mutations in genes involved in the pla nar cell polarity pathway, including Vangl2, have revealed that late gastrulation (the embryonic process resulting in a trilaminar structure comprising ecto derm, mesoderm and endoderm) is defective in these mutant fetuses 37 . The process of convergent extension involves the intercalation of cells in the midline to lengthen and narrow the body axis. When this process fails, as it does in these mouse mutants, the body axis remains short and wide, and the neural folds are spaced abnormally widely apart and are physically unable to initiate closure 37 . depending on the stage at which the wave of zipping arrests. For example, Zic2mutant mice fail early in spi nal neurulation owing to a lack of dorsolateral neural plate bending 38 , and they display a large spina bifida from the thoracic level downwards. By contrast, spi nal closure in the curly tail (Grhl3mutant) mouse fails later owing to enhanced curvature of the body axis 39 , producing a spina bifida confined to the lumbo sacral region. Whether human spina bifida lesions of differ ing axial extents also result from distinct genetic causes remains unclear.
Pathogenesis of closed spinal dysraphism
Secondary neurulation forms the neural tube in the low sacral and coccygeal regions, following closure of the caudal neuropore (FIG. 2d) . The end of the embryo com prises the tail bud (also called the caudal eminence), the mesenchymal cell core of which progressively re organizes into longitudinal cell condensations. The most dorsal of these condensations undergoes canali zation, converting the solid neural precursor into a hollow epithelial secondary neural tube 36, 40 . Secondary neurulation does not have a closure component, so defects (closed spinal dysraphism) are not exposed to the external environment, but are skin covered (FIG. 2e,f) . The principal defect seems to be failure of the neural and mesodermal tissues to become distinctly specified and spatially separated. The presence of neuromeso dermal precursor cells with a bidirectional differentia tion potential in the tail bud 41 might explain why this separation is sometimes incomplete. The clinical obser vation that the distal spinal cord is often tethered to sur rounding tissues in closed spinal dysraphism suggests that this form of NTD can be classified as a disorder of secondary neurulation. However, the frequent and striking association of closed spinal dysraphism with intradural lipoma 42 (FIG. 2f) is not well explained and is yet to be reproduced in an animal model.
Postnatal pathogenesis
Among the different forms of spina bifida, myelomeningo cele is associated with brain malfor mations and hydrocephalus. The main brain defects involve the range of anomalies related to the Chiari II malformation of the hindbrain, which is detected in ~90% of cases 43 . This malformation is associated with development of the cerebellum in a small posterior fossa, such that the cerebellum herniates downwards through the foramen magnum 44 . Quantitative studies of these defects show a reorganization of the cerebellum, such that the anterior part is enlarged, the posterior-inferior regions are reduced, and there is no difference in the corpus medullare (cerebellar white matter) compared with a typical cerebellum 45 . Cerebellar volume reduc tion is more pronounced in thoraciclevel spinal lesions than in lumbar or sacral lesions, but volume reductions relative to typically developing controls are observed in all circumstances 46 . In addition, ~65% of patients with myelomeningocele exhibit distortion of the midbrain, often marked by tectal beaking, in which the colli culi fuse into a single beak that points posteriorly and Nature Reviews | Disease Primers invaginates into the cerebellum. The medulla is elon gated and kinked at the spinomedullary junction in ~70% of patients 43 
(FIG. 3a-c).
The basal ganglia and related subcortical structures of individuals with spina bifida are normal on radiological examination 47 . Quantitative macrostructural assessment shows that the hippocampus, but not the amygdala, is reduced in volume 48 , and the putamen is enlarged. Approximately onethird to half of children with myelo meningocele have hypogenesis (underdevelopment) of the corpus callosum, involving either the splenium and posterior body or the rostrum 43 . These anomalies suggest that the disruption of neural migration that is associated with myelomeningocele is prolonged into the second tri mester of pregnancy, as the corpus callosum develops in weeks 8-20 of gestation 49 . Quantitative studies of the cor pus callosum show marked volume and integrity differ ences between individuals with myelomeningocele and unaffected controls; particularly pronounced differences occur posteriorly when the corpus callosum is hypo genetic or hypo plastic 50 . Reduced integrity has also been shown in the genu but not in the anterior commissure in affected patients 51 . Some evidence supports the theory that corpuscallosal defects are associated with closed spinal dysraphism 52 . Secondary consequences of myelomeningocele might also include hydrocephalus. This condition arises primarily from an obstruction of cerebrospinal fluid flow at the level of the fourth ventricle of the brain, but other contributing factors include aqueductal stenosis, venous haemodynamics and ependymal denudation. Cortical reorganization occurs around the area of ven tricular dilatation. On the basis of quantitative studies, the frontal regions seem to be enlarged and posterior cortical regions reduced in volume compared with controls 53 . Hydrocephalus stretches the white matter, and this is most apparent in the thinned (hypoplastic) appearance of the corpus callosum 54 . Diffusion ten sor imaging of white matter structures shows that the integrity of the long association fibre tracts connect ing the posterior and anterior brain regions is consist ently reduced in affected individuals relative to typically developing controls 55, 56 . Using the midbrain as a refer ence point of origin, it has been shown that individuals with myelomeningocele have a greater reduction in pos terior white matter integrity than in frontal pathways, especially in association with tectal beaking 57 (FIG. 3d- 
i).
Hydrocephalus is accompanied by cognitive and motor abnormalities, the severity of which is linearly associated with the amount of white matter impair ment 58 . The aberrant volumes of frontal versus posteri or regions are associated with reductions in IQ and in dex terity of the fingers 59 . In addition, the specific contri butions of the Chiari II malformation to cognitive and motor outcomes might be underestimated. The Chiari II malformation is associated with eye movement dif ficulties, as well as problems with the precision and tim ing of motor movements and rhythmicity 60 . Attention deficit is also common in patients with myelomeningo cele, reflecting problems with the midbrain and parietal lobe attention systems, which are involved in orienting to salient features of the environment and in arousal. Additionally, tectal anomalies correlate directly with the level of orienting deficits 61 . By contrast, motor skills that are learned through practice, as well as sustained attention and persistence, are generally preserved after the initial phases of learning, possibly reflecting a lower level of impairment in the frontal-striatal regions and basal ganglia 60 . The corpus callosum anomalies in indi viduals with myelomeningocele are associated with reduced interhemispheric communication and difficul ties in integrating information received via language, reading and social interactions 62 . These neurocognitive difficulties can be observed as early as 6 months of age 63 and affect patients through out their lives. They lead to difficulties in learning to construct and assimilate information (assembled processing), in contrast to the relative strengths of affected individuals in associative and procedural learning (associative processing) 64 (TABLE 1) . The char acteristic cognitive strengths and weaknesses associ ated with myelomeningocele are highly variable and poorly reflected by IQ scores. Intellectual disability Nature Reviews | Disease Primers affects ~20-25% of people with myelo meningocele and often only after complications such as hydrocephalus.
A study in the United States has shown that, relative to nonHispanic individuals, Hispanic individuals have a greater frequency of impaired cognitive outcome, and that this is associated with a higher prevalence of upperlevel myelomeningo cele defects and of low socioeconomic status 46 .
Diagnosis, screening and prevention Biochemical diagnosis and screening Prenatal diagnosis first became possible in the early 1970s and was based on an elevated concentration of αfetoprotein in the amniotic fluid of women carry ing fetuses with anencephaly or myelomeningocele 65, 66 . Subsequently, the presence of acetylcholinesterase in amniotic fluid was also shown to be diagnostic 67 . Although αfetoprotein measurement in amniotic fluid samples might be useful for highrisk pregnancies, the 1% chance of miscarriage following amniocentesis has limited the general application of this test. However, it has been found that αfetoprotein levels are elevated in serum samples from mothers carrying fetuses with myelomeningocele 68 , and this finding formed the basis of subsequent populationscreening approaches 69 . Now, with secondtrimester anomaly scanning becoming routine, biochemical screening is becoming redundant, as ultrasonography offers greater sensitivity and speci ficity. Currently, the main indication for biochemical screening is maternal obesity, which can impair detailed ultrasound examination of the fetal anatomy.
Sonographic diagnosis
In parallel with the development of biochemical assays in the 1970s, improvements in ultrasonography facilitated noninvasive diagnosis of myelomeningocele and other NTDs 70 . Today, the fetal spine can be examined by ultra sonography in the sagittal, axial and coronal planes from late in the first trimester onwards, providing the princi pal and most accurate mode of prenatal diagnosis. For reliable detection of myelomeningocele, detailed system atic examination is required in all three planes along the entire length of the spine, from cervical to sacral. This degree of careful examination can detect the majori ty of cases of myelomeningocele, whereas skincovered (closed) lesions are rarely identified in utero. Views of the normal spine juxtaposed with myelomeningocele, to demonstrate the sonographic differences, are shown in FIG. 4 . The spinal lesion is most readily identified when examined in the sagittal plane (FIG. 4a,b) , particu larly if the lesion is associated with a meningocele or myelomeningocele, when the cystic extension is often visible from the posterior aspect of the spine (FIG. 4c,d) . The presence of neural tissue within the sac can often be seen, although ultrasonography cannot reliably exclude the presence of neural tissue. In addition to spina bifida, associated spinal distortions -in varying degrees from virtually none to severe kyphoscoliosis -can also be observed by ultrasonography. Diagnostic ultrasonography images of normally developing fetuses and fetuses with myelomeningocele. Compared with the regular, parallel vertebrae covered with skin in a normal fetus (part a), the spine is protruding from the vertebral column in myelomeningocele (arrow, part b). The low spinal view of a normal fetus (part c) shows the cauda equina within the vertebral canal, whereas in spina bifida, a protruding meningeal cyst is visible (arrow, part d). In a typically developing fetus, the skull has a regular, smooth frontal appearance (part e). By contrast, cranial signs that accompany myelomeningocele include the lemon sign, which is due to scalloping of the frontal bones (arrows, part f). Of note, the size of the anterior horn is also marked in part f. Compared with the dumb-bell shape of the unaffected fetal cerebellum (part g), the banana sign seen in myelomenigocele is characterized by a convex-shaped cerebellum (arrows, part h).
Several cranial features are associated with myelo meningocele, including a disproportionately small bi parietal diameter for gestational age 71 and varying degrees of ventriculomegaly, the latter of which might occur in almost all affected fetuses by the third trimester but is present in up to 70% of spina bifida cases in the second trimester 72 . In the late 1980s, the 'lemon' and 'banana' signs (FIG. 4e-h) were described 73 . The lemon sign refers to a loss of the convex outward shape of the frontal bones, with mild flattening (FIG. 4e,f) , and is present in almost all fetuses with myelomeningocele at between 16 weeks and 24 weeks of gestation (TABLE 2) . After 24 weeks, the lemon sign is detected in only 30-50% of affected fetuses [74] [75] [76] [77] . The banana sign refers to the shape of the cerebellum (FIG. 4g,h ) and is thought to be due to tethering of the spine with downward trac tion on the cerebellum (the Chiari II malformation); it can be detected from 14 weeks onwards 78 . Cerebellar abnormalities are present in 95% of fetuses with myelomeningo cele, irrespective of gestational stage. However, the banana sign is detected most commonly before 24 weeks of gestation (in 72% of all fetuses with myelomeningocele). In later pregnancy, the cerebel lum cannot be detected on ultrasonography in ~80% of affected fetuses, and thus the banana sign is not a reliable indicator 79 . These cranial signs have been important aids to prenatal diagnosis, as the head is examined routinely in all fetuses in the second trimester. Detailed spinal examination might be compromised by fetal position or other technical factors such as maternal habitus. However, detection of the cranial abnormalities should be an indication to ensure that detailed examination of the spine needs to be undertaken, and in many clinics this results in tertiary referral. Routine second trimester ultrasono graphy now detects ~90-98% of fetuses with myelomeningocele in countries that offer second trimester anomaly scanning 80 (TABLE 3) . These screen ing methods are more than 10 years old, and obesity has become increasingly more common in the obstetric population since their development. However, the vast improvements in ultrasonography over time ensures that routine fetalanomaly scanning will continue to have a considerable impact on the prenatal detection of NTDs 81 . According to the UK National Ultrasound Screening Programme, the minimum standard for the detection of this anomaly following routine secondtrimester anomaly scanning should be more than 90% 82 . Following the identification of spina bifida, detailed examination of the fetus is performed to look for other signs that might indicate an associated chromosomal or genetic syndrome, and to seek evidence of neuro logical damage, such as talipes or a dilated renal tract. Karyotyping is offered when other abnormalities are detected or when other risk factors (for example, advanced maternal age) might suggest an associated chromosomal abnormality 77, 83 . Prediction of the spinal level of the lesion is advantageous, as this might deter mine the prognosis. Indeed, threedimensional ultra sonography in one small study has been shown to detect the defect level to one spinal segment in 86% of cases 84 . However, the anatomical level of the lesion frequently does not correspond to the functional level. As a conse quence, ultrasonography was not found to be predictive for postnatal mobility or intellectual function 85 .
Prevention
The prevention of NTDs by maternal folic acid sup plementation has been heralded as a modern public health success 86 . Nearly 40 years ago, Smithells et al. 87 found that diets and postpartum blood levels of women who had a pregnancy affected by NTD were mildly deficient for selected micronutrients, including 77 88.6% (n = 588) 97% (n = 588) 46% (n = 588) 70% (n = 588) Total 91% (n = 815) 97% (n = 758) 49% (n = 700) 71% (n = 696) NR, not reported. *Percentage of abnormalities detected per total number (n) of fetuses with spina bifida. 89 , a randomized trial of NTD first occurrence 90 and a number of observa tional epidemiological studies all provided evidence that folic acid supplements can prevent NTDs from occur ring during pregnancy. Now, women at high risk, includ ing those with a previous history of an NTDaffected pregnancy, are recommended to take 4 mg of folic acid per day while planning a pregnancy, whereas those at low risk are advised to take 0.4 mg per day 86 . Concerns about the effectiveness of voluntary sup plementation have led to policy decisions in many coun tries, including the decision to fortify staple foods with folic acid. Mandatory folic acid fortification of cereal grain products in the United States began in January 1998 and has been associated with an ~25% reduction in the prevalence of NTDs 91 . Implementation of man datory fortification programmes elsewhere -such as in Chile 92 98 , by contrast, did not report a reduced NTD prevalence after fortification programmes. The relative reduction in prevalence seems to be roughly correlated with the magnitude of the initial prevalence of NTDs. Some countries, such as Australia, have also observed reductions in NTD prevalence after implementing programmes of voluntary folic acid supplement use or fortification 99 . Whether to establish mandatory fortifica tion programmes in European countries remains much debated. Some scientists have questioned whether these programmes should go further towards reaching suscep tible pregnancies 100 , whereas others have expressed the need to balance the benefits of NTD prevention with possible risks (such as potential masking of vitamin B12 deficiency or enhanced growth of premalignant lesions) for other sections of the population 101, 102 .
Management
The management of myelomeningocele tradition ally involves surgery within 48 hours of birth. The child's back is closed to minimize the risk of ascend ing infection, which can otherwise result in meningitis.
However, an earlier intervention involving fetal surgery has now been implemented in a number of centres, with promising results.
Postnatal surgery and management
Newborn babies with myelomeningocele are best man aged following baseline imaging studies of the central nervous system, and subsequent serial head measure ments to assess the velocity of head growth and the need for shunting. Almost all newborns with thoracic level lesions need a ventriculoperitoneal shunt
, whereas ~85% of patients with a lumbarlevel lesion and ~70% with a sacrallevel lesion require this inter vention 103 . Over the past 5 years, combined endoscopic third ventriculostomy and choroid plexus coagula tion (BOX 3) has become an alternative treatment for hydrocephalus associated with spina bifida in selected cases 104 . Radiological evidence of the Chiari II malfor mation is present in most affected individuals, and clin ically symptomatic hindbrain herniation can affect up to 30% of patients. Symptoms of this herniation include apnoea, swallowing difficulties and stridor in a new born baby, or headache, quadriparesis, scoliosis, and balance and/or coordination issues in an older child months or years later. In severe cases, posterior fossa decompression surgery is indicated 105 . Orthopaedic deformities are usually treated shortly after birth, but they require longterm followup. Patients are also monitored by ultrasonography and urodynamic studies to detect urological complications resulting from abnormal neurological control of blad der function. Possible complications include urinary retention with overflow and ureteric reflux, which can lead to recurrent urinary tract infections and, ultimately, deteri oration of renal function. Bladder and urinary tract management often involves a combination of clean, intermittent catheterization, pharmacological agents and surgery 106 . Bowel function is not an issue in new borns, but older children require bowel management treatments such as suppositories, laxatives, or antegrade colonic or traditional enemas 107, 108 . Medical management is best provided through regu lar assessments by a multidisciplinary team, including a nurse specializing in the care of children with mul tiple handicaps, a paediatric neurosurgeon, a urolo gist, an orthopaedic surgeon, a physical therapist and a social worker. Other subspecialists (for example, a psy chologist) can be involved if required. Communication between the multidisciplinary team members and the patient's primary physician is vital. Additional issues that might need to be addressed by the team include neurobehavioural development, mobility and means of locomotion, weight maintenance, skin care and the avoidance of latex sensitization.
Fetal surgery
The rationale for fetal surgery 109 is that damage to the exposed spinal cord progresses during gestation. Hence, early repair of the lesion in utero might prevent continuing damage and improve clinical outcome. Additionally, myelomeningocele repair arrests the Box 3 | Surgical treatments for myelomeningocele
• Choroid plexus coagulation: the cerebrospinal fluid (CSF)-producing choroid plexus is coagulated endoscopically to prevent further CSF production, which otherwise exacerbates the hydrocephalus.
• Ventriculoperitoneal shunt: a shunt is inserted to drain CSF from the brain ventricles into the peritoneal cavity.
• Ventriculostomy: a small perforation is made in the thinned floor of the third ventricle, allowing movement of CSF out of the blocked ventricular system and into an adjacent space that is normally filled with CSF.
leak of cerebrospinal fluid from the lesion, enabling the reversal or resolution of hindbrain herniation [110] [111] [112] . Pregnant mothers carrying a fetus with diag nosed myelomeningocele who consider in utero sur gery undergo extensive prenatal testing. This testing includes an obstetric evaluation, screening for genetic or chromo somal syndromes, and ultrasonography of the fetus to assess leg function, identify defects including talipes and determine the spinal level of the vertebral arch anomalies. Fetal echocardiography is used to iden tify any co existing cardiac defects, and ultrafast MRI is used to detect the features of the Chiari II malforma tion, including hindbrain herniation and other brain anomalies, and to determine the presence or absence of hydrocephalus 113 . Fetal myelomeningocele surgery is conducted according to an intraoperative and postoperative man agement algorithm 114 . The surgery involves maternal laparotomy (abdominal wall incision), after which a uterine stapling device is used to create a 6-8 cm hys terotomy (uterine incision) of sufficient size to expose the fetal lesion (FIG. 5) . Intraoperative echocardiography is used throughout the procedure to monitor fetal heart function 115 . Closure of the defect follows a standard pro cedure similar to that used postnatally: the cystic mem brane is excised, meningeal attachments to skin and soft tissues are mobilized, and the neural placode is separated from surrounding tissue and positioned in the spinal canal. If possible, the dura is identified, reflected over the placode and closed with sutures. Paraspinal myofascial flaps are created and closed in the midline. Skin flaps are then used to complete the repair (FIG. 5) , but if the skin cannot be closed primarily, the procedure is completed using an acellular human dermis graft.
Successful in utero spina bifida repair was first reported in 1998 (REFS 116, 117) . Clinical use grew rap idly thereafter, with promising results, but without compelling proof of safety or efficacy 110, 111 . When a human fetus with spina bifida reaches 22 weeks of gestation, the mother and fetus can undergo surgery to repair the fetal spinal lesion. First, a hysterotomy is made in the mother by a uterine stapler, exposing the myelomeningocele lesion and neural placode (part a). This is followed by closure of the myelomeningocele lesion using a dural and myofascial flap (part b).
group had higher and more severe myelomeningocele lesions than those in the postnatalsurgery group. Significantly less hindbrain herniation occurred in the fetalsurgery group than in the postnatalsurgery group. However, premature birth was significantly more com mon after fetal surgery than in the postnatalsurgery group. In addition, ~25% of women whose babies under went fetal surgery showed evidence of thinning of the uterine wound at the time of delivery, and 10% showed tissue edge separation at the hysterotomy site (9% showed partial separation and 1% complete separation), although none had a hysterotomy rupture. As a result of the MOMS trial, three options are now available for women carrying a fetus diagnosed with myelomeningocele at less than 24 weeks of gestation. They can choose to terminate the pregnancy; to continue the pregnancy with delivery by nearterm caesarean sec tion followed by postnatal repair; or to undergo pre natal surgery, provided that the eligibility criteria are satisfied
. Financial modelling of data from the MOMS trial has identified a health care saving of more than $2 mil lion for every 100 cases of fetal myelomeningocele repair undertaken 119 . However, longterm followup of children who receive fetal repair will be crucial to assess whether the early benefits are enduring. To this end, the MOMS trial patients will now be followed up to the age of 6-10 years in a US National Institutes of Healthfunded study. The clinical experience with fetal myelomeningo cele repair during the past 3 years has shown compara ble results to the MOMS trial 120 . Institutional guidelines have also been established, and it is clear that to optimize patient safety and outcome, fetal myelomeningocele surgery should be conducted only in highvolume fetal surgery centres that follow a standardized patient care protocol 121 . The North American Fetal Therapy Network has established a data registry to collate the outcomes for patients who have the surgery.
Quality of life
Spina bifida has a pervasive impact on the physical, neurocognitive, psychological and social functioning of affected individuals [122] [123] [124] (FIG. 6) .
Health-related quality of life Children and adolescents with spina bifida have a lower healthrelated quality of life than both individuals with out spina bifida and children with other chronic health conditions. These differences tend to be stable across age groups, sexes and geographical locations, and they seem to continue throughout a patient's life 125, 126 . Although measures of severity, such as lesion level, continence status and outcomes of various surgical procedures, tend not to correlate with healthrelated quality of life 126, 127 , other factors do have a correlation, particularly the pres ence of shunted hydrocephalus and lack of mobility 128, 129 .
Other robust predictors of healthrelated quality of life include socioeconomic status, pain levels, parenting stress and other family factors 126, 130 .
Psychosocial adjustment
During late childhood, individuals with spina bifida tend to have higher levels of depressive symptoms and lower levels of selfesteem than unaffected individu als [131] [132] [133] . They also have social difficulties, including social immaturity and passivity, having fewer friends and social contacts outside school, and having fewer romantic relationships during adolescence 131, 134, 135 . Most of these difficulties seem to be maintained into young adulthood 132 . Children and adolescents with spina bifida also depend more on adults for guidance, show less intrinsic motivation at school and exhibit less behavioural autonomy at home. They express their own viewpoints less frequently than typically developing individuals during family interactions 131, [136] [137] [138] .
Family functioning
Functioning of the families of children and adolescents with spina bifida 139 is characterized by a resiliencedisruption model 140 . This model is based on the concept that a child with spina bifida might disrupt some norma tive family functions, but many families exhibit consider able resilience, are able to adapt to such disruption and often exhibit similar levels of conflict as families with only typically developing children. Approximately 10-15% of families affected by spina bifida exhibit clinical levels of family dysfunction 141, 142 , but these rates are lower than the 35% of clinical family dysfunction found among families containing children with cerebral palsy 142 . The combi nation of lower socioeconomic status and parenting a child with spina bifida further increases the risk of lower levels of family cohesion, which supports a cumulative risk model for these families 143 . Studies of marital functioning among parents of children with spina bifida have yielded mixed results [144] [145] [146] , although the quality of the relationship before the affected child was born has emerged as an important predictor of subsequent family adjustment. A metaanalysis of 15 studies revealed a consistent negative impact of spina bifida on the psychological adjustment of parents, with an effect size that was larger, but more heterogeneous, for mothers (d = 0.73) than for fathers (d = 0.54) 147 . The study also showed negative effects on parental stress levels and parenting quality 138, 148 . Typical findings are that parents of chil dren with spina bifida feel more isolated, are less satis fied and/or competent as parents, are less adaptable to change and hold less optimistic views about the future than parents of typically developing children 145, 149, 150 . This particularly applies to parents who are single, are at the older end of the parental age range, experience social isolation, or are from a nonwhite background or a low socioeconomic background 143, 151 . Siblings of children with spina bifida benefit in their personal adjustment when they experience positive family atti tudes to spina bifida, greater overall family satisfaction and lower levels of sibling conflict 152 .
Adult outcomes
The mortality rate among young people with spina bifida is ~1% per year between 5 and 30 years of age, with the rate being highest among those with the highestlevel lesions 153, 154 . Among survivors, the quality of the individ ual's health tends to decline from adolescence to young adulthood, presumably owing to difficulties in navigat ing the transition to adult health care [155] [156] [157] . Similar to their younger counterparts, emerging adults with spina bifida are at increased risk of depressive symptoms and anxiety 129, 158 . They are, however, less likely to engage in risky behaviours such as alcohol use and multiple sexual partners, possibly owing to their lower rates of social integration 159 . Regarding educational and vocational outcomes, 41-56% of young adults with spina bifida go to college compared with 66% of typically developing young people 128, 153, 160, 161 . Moreover, recent studies report that only 36-48% of individuals with spina bifida are in fulltime or parttime employment 128, 156, [161] [162] [163] , which is significantly lower than the rate for typically developing young people (which is 75% 160, 161, 164 ) and for those with other chronic conditions (which is 68% for individuals with asthma and 78% for individuals with cancer 156, 165 ). Moreover, half of individuals with spina bifida who work have parttime positions, and their annual salary is therefore below the US national average 128 . With respect to relationship quality, 43-77% of adults with spina bifida live with their parents 128, 153 . Just over half (52-68%) have had a romantic relationship 128 , which is less than in typically developing young adults 161, 166 . The lowest level of life satisfaction is in the areas of romantic relation ships, employment and financial independence 128 . Parents of young people with spina bifida are less likely to dis cuss issues of sexuality with their children 134, 167 , and most affected individuals have an inadequate level of knowledge in this area 168 . The high rate of obesity in this population (rates tend to be >40% (REF. 169)), coupled with continence issues, probably undermine these young adults' efforts to have romantic relationships 169, 170 . Moreover, participation in leisure and recreational activities tends to be low, with >50% failing to participate 171 . The most common barriers are lack of motivation, lack of information and time con straints 171 . Younger individuals and those without shunts tend to participate more than older and moreimpaired individuals 172 . Generally, the best predictors of successful navigation of young adult milestones seem to be condition related (an absence of hydrocephalus, and good mobil ity 128 ), neuropsychological (executive functioning 161 ), personality based (intrinsic motivation 161 ), familial (socio economic status and parental intrusiveness 161 ) and logisti cal (transportation and accessibility 173 ). Other influential factors include financial aspects (concerns about lack of health insurance 174 ), lack of job training and vocational rehabilitation services, discrimination during employ ment, physicalappearance stigmas and earlychildhood socialization problems 170, 175, 176 . Outlook Spina bifida affects individuals, their families, medi cal science and society in a variety of ways. Looking forward, it is exciting to discern a number of areas in which our understanding of this multifaceted condition is likely to advance, both by enhancing our ability to promote primary prevention and by improving the lives of individuals who have spina bifida.
Genetic basis
For spina bifida, like many other diseases, efforts to unravel the cause of the disorder will be enhanced by the application of recently developed highthroughput genomic and epigenomic technologies. Exome sequenc ing is already being applied on a small scale 177 . However, even if causal genetic variants are identified in individuals or families with spina bifida, many are likely to be irrel evant to spina bifida causation on a wider scale. Moreover, genetic risk might be imparted by noncoding DNA variants (such as enhancer polymorphisms) and specific epigenetic signatures 178, 179 , neither of which is detected by exome sequencing. What is needed is a general and unbiased approach, at the level of multinational consor tia, to identify genomic and epigenomic alterations within groups of individuals with spina bifida (and other NTDs) compared with unaffected controls 179 . With continued reductions in the cost and increases in the speed of high throughput technologies, the application of more compre hensive and integrated 'omics' methodologies, including protein and metabolite detection and quantitation, seems likely to be implemented in the coming years 180 .
Preventive action of folic acid
The mechanism by which folic acid prevents spina bifida and other NTDs remains unclear, and experimental studies will be aimed at elucidating this important aspect of primary prevention (FIG. 7) . Exogenous folic acid might enhance embryonic cell proliferation through stimula tion of pyrimidine and purine synthesis. This hypothesis is supported by the finding that embryonic cells undergo disordered proliferation in several mouse models of NTDs 181 . Another possibility is that folic acid enhances the methylation of key macromolecules, including DNA.
Thus, by interfering with the epigenetic regulation of early nervous system development, the compound might affect embryonic gene expression 178, 179 . A more controversial hypothesis is that sometimes folic acid might not protect from neural tube closure defects, but rather might exacerbate these problems, thereby worsen ing fetal outcomes and leading to miscarriages 182 . Such a detrimental effect, termed terathanasia, could in princi ple account for a reduced NTD prevalence in later preg nancy, as most affected pregnancies would have been lost earlier. In mice, multigenerational treatment with highdose folic acid increased the frequency and sever ity of NTDs in three mutant mouse strains 183 . However, in another mouse strain, NTDs were reduced by folic acid administration and increased by dietary folate defi ciency 184 , consistent with a role of these compounds in true primary prevention. When we are able to identify specific subgroups of human spina bifida, for example from their genetic risk factors, it might be possible to determine whether folic acid supplementation also has these opposing actions in humans.
Prevention by other metabolites
Finding the means to prevent more cases of spina bifida is a priority for future research and public health implemen tation. Folic acid food fortification is likely to be extended to countries where this is not currently practised 100 , and supplements containing vitamin B12, a cofactor in folate onecarbon metabolism, might further reduce the fre quency of NTDs 185 . In addition, apparent 'folate non responsiveness' is being increasingly observed, as women continue to experience spina bifidaaffected pregnancies despite taking folic acid supplements. Some NTDs might fail to respond to exogenous folic acid owing to defects in the folate transport system (that is, the metabolic enzymes required to transfer onecarbon units to key downstream metabolites); such defects could prevent folic acid from being metabolized. In this case, supplementation with alternative folates, such as 5methyltetrahydrofolate 186 , or with key downstream molecules such as nucleotide precursors 187 might enhance primary prevention (FIG. 7) . Alternatively, some NTDs can arise from an embry onic defect that cannot be corrected by altering folate onecarbon metabolism, and quite different preventive strategies might be required. Prominent among these strategies is addition of the small molecule inositol, which is essential for a number of intracellular signalling pathways and is a building block for membrane phospho lipids. Inositol supplementation can prevent NTDs in a folatenonresponsive mouse strain 188 , and has proved to be well tolerated and associated with normal fetal out comes in a group of women whose fetuses are at high risk of developing spina bifida Maternal supplementation with folic acid prevents many cases of spina bifida, most probably through its regulation of epigenetic modifications (methylation) and/or cell proliferation (through a role in the synthesis of purines and pyrimidines) in the embryo, although the exact mechanism is incompletely understood. However, defects in enzymes involved in these pathways might mean that folic acid supplementation alone is inadequate and point to the need to supplement with other metabolites (green boxes). Thus far, mutations in the genes encoding several enzymes involved in the folate one-carbon metabolism pathway (especially in the gene encoding 5,10-methylenetetrahydrofolate reductase (MTHFR); maternal and fetal mutations) and the glycine cleavage system (which produces formate in the mitochondria; fetal mutations only) have been definitively associated with increased risk of spina bifida. Solid arrows indicate the key metabolic reactions. Dashed arrows indicate metabolic pathways that involve multiple reactions.
the lesion, neurological function might be enhanced after birth. To date, stem cells have been transplanted into rat and sheep fetuses with myelomeningocele. These studies used mesenchymal stem cells, neural stem cells and skin derived induced pluripotent stem cells that were treated to enhance neural crest cell differentiation, and all three cell types survived for variable periods after transplan tation [191] [192] [193] . Importantly, biodegradable tissue scaffolds have been successfully inserted in the lesion during the in utero operation, enabling cells to be seeded and grown on the scaffold prior to transplant 193 . However, using autologous (hostderived) amniotic fluidderived stem cells for transplantation, to minimize the risk of graft rejection, might prove problematic. Indeed, these cells, when isolated from human fetuses with spina bifida, fail to deposit collagen type I and show lower collagenrelated gene expression than cells from the amniotic fluid of nor mal fetuses 194 . A further stem cellrelated advance has been the demonstration that autologous bone marrow derived stem cells can be used in combination with a tis sue scaffold to enable bladder tissue engineering. This strategy might replace enterocystoplasty (in which bowel wall is used to reconstruct the bladder), a procedure com monly performed in children with myelomeningocele. Clearly, a great deal of work will be needed, both in vitro and in animal models, to develop optimal protocols for both efficacy and safety before stem cell transplants can be considered in human fetuses. Furthermore, to maxi mize the effectiveness of any potential in utero treat ment, early sonographic diagnosis will be needed, and this will require the development of routine screening programmes delivered at ~12 weeks of gestation.
Psychosocial interventions
Several domains in the lives of individuals with spina bifida need further research. This is exemplified by the current lack of familybased intervention studies for the families of young people with spina bifida 139 , in contrast to the extensive literature in this area for other chronic physical conditions (for example, type 1 diabetes melli tus). Although few randomized clinical trials have been reported in any of the salient psychosocial domains (quality of life, social skills, independent decision mak ing and depressive symptoms), one small randomized study of adults with spina bifida found that goal man agement training reduced anxiety and psychological distress 195 . A manualized summer campbased interven tion has also been developed that targets independence and social skills among children, adolescents and young adults with spina bifida. The intervention included col laborative (that is, parent and camper) goal identifica tion, group sessions consisting of psychoeducation and the acquisition of cognitive tools, and goal monitoring by camp counsellors. Goals for each camper included a medically related goal (for example, catheterizing inde pendently) and a social goal (for example, making a new friend during camp). Statistically significant gains were found both in individualized goals and in the independ ent management of spina bifidarelated responsibilities, with medium effect sizes 196 . Such gains were main tained at a 1month followup, and the findings have since been replicated with larger effect sizes 197 . Progress towards the objective evaluation of such interventions could considerably improve the lives of individuals with spina bifida.
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